Serial #79271791
LIVE

Serial Number

79271791

Owner

Synplogen Co., Ltd.

Attorney

Kumiko Ide

Filing Date

Aug 22, 2019

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79271791 Trademark

Serial Number: 79271791 • Registration: 6055780

Serial #79271791 is a trademark filed by Synplogen Co., Ltd. on August 22, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Synplogen Co., Ltd. (4 trademarks)

1-1 Rokkodai-cho,

Entity Type: 03

Trademark Details

Filing Date

August 22, 2019

Registration Date

May 19, 2020

Published for Opposition

March 3, 2020

Goods & Services

Research and development relating to DNA synthesis technology; technical advisory services and * providing * information technology [ services ] relating to DNA synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, quality control, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; technical advisory services and * providing * information technology [ services ]relating to genome synthesis technology; research and development, quality control, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; * providing * information technology [ services ] relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; testing, inspection or research relating to medical treatment or medical technology with genome synthesis technology; information technology services for testing, inspection or research relating to medical treatment or medical technology with genome synthesis technology; testing or research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; testing, inspection or research on agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; DNA synthesis services for others; research and development services in the field of gene expression systems; research and development services in the fields of microorganisms and cells; [ DNA sequence design services; ] research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; technical research in the field of microorganisms; bacteriological research; biological research

Filing History

TEAS SECTION 71 RECEIVED
Apr 21, 2026 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 19, 2025 REM3
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Nov 30, 2022 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 6, 2022 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 30, 2022 NREP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Mar 7, 2022 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Mar 6, 2022 COC.
LIMITATION OF GOODS RECEIVED FROM IB
Feb 5, 2022 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 11, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 21, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 21, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 19, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
May 19, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Feb 28, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 12, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 29, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 29, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 29, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 29, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 14, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 14, 2020 TROA
REFUSAL PROCESSED BY IB
Jan 4, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 19, 2019 RFCS
REFUSAL PROCESSED BY MPU
Dec 19, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 22, 2019 RFCR
NON-FINAL ACTION WRITTEN
Nov 21, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 19, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 14, 2019 REPR